A population-based study of 618,739 adults using electronic health record data, published in the Clinical Journal of the American Society of Nephrology by Katherine R. Tuttle, Lindsey M. Kornowske, Cami R. Jones, Christina L. Reynolds, Radica Z. Alicic, Kenn B. Daratha, Joshua J. Neumiller, O. Kenrik Duru, Susanne B. Nicholas, Meda E. Pavkov, on behalf of the CURE-CKD Consortium, has found that people with diabetes and reduced estimated glomerular filtration rate (eGFR) faced significantly higher risks of mortality and kidney failure. The study highlights how the coexistence of diabetes and impaired kidney function magnifies the risk burden, underscoring the importance of early recognition and proactive management in chronic kidney disease (CKD). The authors emphasize that protecting kidney and cardiovascular health requires an integrated and patient-centered approach, particularly for populations with overlapping metabolic and renal vulnerabilities.
The real-world cohort analysis examined outcomes in a large population across diverse clinical settings, making the findings highly relevant to everyday practice. Patients with both diabetes and reduced eGFR consistently showed the highest incidence of death and kidney failure compared to those without diabetes or with preserved renal function. The results reflect the complex interplay between metabolic and renal pathways, where diabetes accelerates kidney injury, and impaired kidney function worsens cardiovascular and systemic risks. By leveraging real-world data, the study provides strong evidence that these patients represent a critical group requiring close monitoring, comprehensive care, and early interventions to prevent adverse outcomes.
The authors conclude that clinicians should adopt integrated models of care that address both renal and cardiovascular complications in patients with diabetes and CKD. This includes optimizing blood glucose control, monitoring renal function, managing blood pressure, and incorporating lifestyle modifications. The findings also call for healthcare systems to prioritize coordinated strategies that reduce fragmentation in CKD management. As diabetes continues to rise globally, and CKD remains a leading cause of morbidity and mortality, the study strengthens the case for preventive strategies and patient-centered care to reduce disease burden.
Keywords: diabetes, chronic kidney disease, eGFR, kidney failure, mortality, patient-centered care, Clinical Journal of the American Society of Nephrology, CURE-CKD Consortium, population-based study
Reference: Tuttle KR, Kornowske LM, Jones CR, Reynolds CL, Alicic RZ, Daratha KB, Neumiller JJ, Duru OK, Nicholas SB, Norris KC, Pavkov ME; on behalf of the CURE-CKD Consortium. A Real-World Cohort Study of the Risks of Kidney Failure and Death in Diabetes.
Clin J Am Soc Nephrol. 2025. doi:
10.2215/CJN.0000000857 .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.